These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3470054

  • 41. Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia.
    Yamauchi T, Kawai Y, Goto N, Kishi S, Imamura S, Yoshida A, Urasaki Y, Fukushima T, Iwasaki H, Tsutani H, Masada M, Ueda T.
    Jpn J Cancer Res; 2001 Sep; 92(9):975-82. PubMed ID: 11572766
    [Abstract] [Full Text] [Related]

  • 42. Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells.
    Akman SA, Ross DD, Joneckis CC, Fox BM, Bachur NR.
    Cancer Treat Rep; 1985 Sep; 69(7-8):851-7. PubMed ID: 4016794
    [Abstract] [Full Text] [Related]

  • 43. Rapid in-vitro testing for chemotherapy sensitivity in leukaemia patients.
    Anderson E, Salisbury V.
    Adv Biochem Eng Biotechnol; 2014 Sep; 145():189-214. PubMed ID: 25216956
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.
    Wang LM, White JC, Capizzi RL.
    Cancer Chemother Pharmacol; 1990 Sep; 25(6):418-24. PubMed ID: 2311169
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S, Boise L, Westin E, Howe C, Pettit GR, Turner A, McCrady C.
    Biochem Pharmacol; 1991 Jul 25; 42(4):853-67. PubMed ID: 1867641
    [Abstract] [Full Text] [Related]

  • 54. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S, Bhalla K, Rauscher F, Cadman E.
    Cancer Res; 1983 Nov 25; 43(11):5093-100. PubMed ID: 6577943
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Patient-specific dose rate for continuous infusion high-dose cytarabine in relapsed acute myelogenous leukemia.
    Heinemann V, Estey E, Keating MJ, Plunkett W.
    J Clin Oncol; 1989 May 25; 7(5):622-8. PubMed ID: 2709090
    [Abstract] [Full Text] [Related]

  • 58. Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
    Harris AL, Grahame-Smith DG, Potter CG, Bunch C.
    Clin Sci (Lond); 1981 Feb 25; 60(2):191-8. PubMed ID: 6940687
    [Abstract] [Full Text] [Related]

  • 59. Efficient formation of cytosine arabinoside-5'-triphosphate in leukemic blasts of human T-cell acute lymphoblastic leukemia.
    Tanaka M, Yoshida S.
    Leuk Res; 1989 Feb 25; 13(10):931-6. PubMed ID: 2586146
    [Abstract] [Full Text] [Related]

  • 60. Variation in sensitivity of DNA synthesis to ara-C in acute myeloid leukaemia.
    Harris AL, Grahame-Smith DG.
    Br J Haematol; 1980 Jul 25; 45(3):371-9. PubMed ID: 6932952
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.